Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

CA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...

Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...

Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...

Kiran Mazumdar-Shaw refuted Karnataka CM Siddaramaiah's claim. Siddaramaiah linked covid-19 vaccines to heart attack deaths ...